NRTI Use Linked to Risk for Primary Open-Angle Glaucoma
By Elana Gotkine HealthDay Reporter
TUESDAY, July 8, 2025 -- Use of nucleoside and nucleotide reverse transcriptase inhibitors (NRTIs) is associated with an increased risk for primary open-angle glaucoma (POAG), according to a study published online June 20 in Ophthalmology.
Kenneth Pham, from the University of Pennsylvania in Philadelphia, and colleagues conducted a retrospective cohort study involving 305,441 adults aged 40 years or older with linked electronic health record data from the National Institutes of Health All of Us dataset to assess the association of NRTI use with POAG. A cohort of 1:10 NRTI users to nonusers was created using a propensity score-matching design; 718 individuals with NRTI use were identified and matched with 7,180 nonusers.
The researchers found that the rate of POAG was 4.32 percent in NRTI users and 2.00 percent in the propensity score-matched control group. POAG risk was increased in association with NRTI use (odds ratio, 2.21). NRTI use remained significantly associated with an increased risk for developing POAG after adjustment for residual imbalance of family history of POAG, HIV diagnosis, and hepatitis B diagnosis (odds ratio, 1.84). NRTIs remained significantly associated with POAG risk after matching and adjusting for self-reported eye doctor visits (odds ratio, 2.30).
"A possibility that could explain the association between NRTI use and POAG risk is that increased medical surveillance associated with NRTI use could allow greater opportunity for POAG diagnosis, though we have performed multiple analyses to detect such a mechanism," the authors write. "Moreover, analyses for cataracts and angle-closure glaucoma did not reveal an association between NRTI use and those other eye conditions. Together, these results do not find evidence that higher POAG rates observed among NRTI users can merely be attributed to more examination of the eyes."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted July 2025
Read this next
Drop in Mental Health Scores Seen With Primary Open-Angle Glaucoma Diagnosis
MONDAY, June 9, 2025 -- Diagnosis of primary open-angle glaucoma (POAG) is associated with a reduction in mental health scores, according to a study published online June 5 in...
Swept-Source Anterior Segment OCT Can Help Distinguish Early Childhood Glaucoma
FRIDAY, May 23, 2025 -- The noninvasive swept-source anterior-segment optical coherence tomography (SS-ASOCT) can diagnose early-onset childhood glaucoma, according to a study...
Elevated HDL Cholesterol Linked to Increased Risk for Glaucoma
WEDNESDAY, Feb. 5, 2025 -- Elevated high-density lipoprotein cholesterol (HDL-C) is associated with an increased risk for glaucoma, while elevated low-density lipoprotein...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.